Infections in systemic lupus erythematosus

Lupus

Volumn 19, Issue 12, 2010, Pages 1419-1424

  Navarra, S V ^a   Leynes, Msn ^a  

^a UNIVERSITY OF SANTO TOMAS   (Philippines)

Author keywords

immunizations; immunosuppression; infections; systemic lupus erythematosus

Indexed keywords

ALPHA INTERFERON; ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; CYCLOPHOSPHAMIDE; HEPATITIS VACCINE; HTLV 1 RELATED ENDOGENOUS SEQUENCE 1 PROTEIN; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; INTERFERON; ISONIAZID; LUPUS ANTICOAGULANT; MANNOSE BINDING LECTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PNEUMOCOCCUS VACCINE; PREDNISONE; RITUXIMAB; SMALL NUCLEAR RIBONUCLEOPROTEIN; STEROID; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBODY TITER; ASIAN; BACTERIAL ARTHRITIS; BRAIN ABSCESS; CELLULAR IMMUNITY; CLINICAL TRIAL; CRYPTOCOCCUS NEOFORMANS; DISEASE ACTIVITY; EPSTEIN BARR VIRUS; ESCHERICHIA COLI; EXTRAPULMONARY TUBERCULOSIS; FILIPINO; HEPATITIS C; HUMAN; HUMORAL IMMUNITY; INFECTION; INFECTION SENSITIVITY; MENINGITIS; MOLECULAR MIMICRY; MYCOBACTERIUM TUBERCULOSIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SALMONELLA; SALMONELLOSIS; STAPHYLOCOCCUS AUREUS; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; TORQUE TENO VIRUS; TUBERCULOSIS; VACCINATION;

ASIA; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INFECTION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MORBIDITY; SURVIVAL RATE;

EID: 78649741341     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310374486     Document Type: Review

References (76)

1. Cooper GS, Gilbert KM, Greidinger EL, et al. Recent advances and opportunities in research on lupus: environmental influences and mechanisms of disease. Environ Health Perspect 2008 ; 116: 695-702.
2. Sebastiani GD, Galeazzi M. Infection-genetics relationship in systemic lupus erythematosus. Lupus 2009 ; 18: 1169-1175.
3. Petri M. Infection in systemic lupus erythematosus. Rheum Dis Clin North Am 1998 ; 24: 423-456.
4. Navarra SV, King JO An overview of clinical manifestations and survival of systemic lupus erythematosus in Asia. APLAR J Rheumatol 2006 ; 9: 336-341.
5. Wadee S., Tikly M., Hopley M. Causes and predictors of death in South Africans with systemic lupus erythematosus. Rheumatology (Oxford) 2007 ; 46: 1487-1491.
6. Pons-Estel BA, Catoggio LJ, Cardiel MH, et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among " Hispanics". Medicine (Baltimore) 2004 ; 83: 1-17.
7. Houman MH, Smiti-Khanfir M., Ben Ghorbell I., Miled M. Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients. Lupus 2004 ; 13: 204-211.
8. Mok CC, Mak A., Chu WP, To CH, Wong SN Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Medicine (Baltimore) 2005 ; 84: 218-224.
9. Koh ET, Seow A., Leong KH, Chng HH SLE mortality in an oriental population. Lupus 1997 ; 6: 27-31.
10. Malaviya AN, Chandrasekaran AN, Kumar A., Shamar PN Systemic lupus erythematosus in India. Lupus 1997 ; 6: 690-700.
11. Yeap SS, Chow SK, Manivasagar M., Veerapen K., Wang F. Mortality patterns in Malaysian systemic lupus erythematosus patients. Med J Malaysia 2001 ; 56: 308-312.
12. Navarra STV. Infectious agents in arthritis and autoimmunity. Mod Rheumatol 2003 ; 13: 97-102.
13. Fujinami RS Viruses and autoimmune disease - two sides of the same coin? Trends Microbiol 2001 ; 9: 377-381.
14. Agmon-Levin N., Blank M., Paz, Shoenfeld Y. Molecular mimicry in systemic lupus erythematosus. Lupus 2009 ; 18: 1181-1185.
15. James JA, Harley JB, Scofield RH Role of viruses in systemic lupus erythematosus and Sjogren syndrome. Curr Opin Rheumatol 2001 ; 13: 370-376.
16. Reveille JD The changing spectrum of rheumatic disease in human immunodeficiency virus infection. Semin Arthritis Rheum 2000 ; 30: 147-166.
17. Ramos-Casals M., Muñoz S., Medina F., et al. Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases: the HISPAMEC Registry. J Rheumatol 2009 ; 36: 1442-1448.
18. Berkun Y., Zandman-Goddard G., Barzilai O., et al. Infectious antibodies in systemic lupus erythematosus patients. Lupus 2009 ; 18: 1129-1135.
19. James JA, Neas BR, Moser KL, et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum 2001 ; 44: 1122-1126.
20. Moore TL, Bandlamudi R., Alam SM, Nesher G. Parvovirus infection mimicking systemic lupus erythematosus in a pediatric population. Semin Arthritis Rheum 1999 ; 28: 314-318.
21. Kalt M., Gertner E. Antibodies to b2-Glycoprotein I and cardiolipin with symptoms suggestive of systemic lupus erythematosus in parvovirus B19 infection. J Rheumatol 2001 ; 28: 2335-2336.
22. Lu JJ-Y, Chen D-Y., Hsieh C-W., Lan J-L., Lin F-J., Lin S-H. Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan. Lupus 2007 ; 16: 168-175.
23. Kawashiri S-Y., Nakamura H., Kawakami A., et al. Emergence of Epstein-Barr virus-associated haemophagocytic syndrome upon treatment of systemic lupus erythematosus. Lupus 2006 ; 15: 51-53.
24. Gergely P., Perl A., Poor G. Possible pathogenic nature of the recently discovered TT virus: Does it play a role in autoimmune rheumatic diseases? Autoimmunity Rev 2006 ; 6: 5-9.
25. Fox R., Isenberg DA Human immunodeficiency virus infection in systemic lupus erythematosus. Arthritis Rheum 1997 ; 40: 1168-1172.
26. Palacios R., Santos J., Valdivielso P., Marquez M. Human immunodeficiency virus infection and systemic lupus erythematosus. An unusual case and a review of literature. Lupus 2002 ; 11: 60-63.
27. Gold J., Haubenstock A., Zalusky R. Lupus anticoagulant and AIDS. N Engl J Med 1986 ; 314: 1252-1253.
28. Stimmler M., Quismorio F., McGehee W., et al. Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch Int Med 1989 ; 149: 1833-1835.
29. Savige JA, Chang L., Crowe SM Antinuclear, antineutrophil cytoplasmic and antiglomerular basement membrane antibodies in HIV-infected individuals. Autoimmunity 1994 ; 18: 205-211.
30. Perl A., Colombo E., Dai H., et al. Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes. Arthritis Rheum 1995 ; 38: 1661-1672.
31. Magistrelli C., Samoilova RK, Agarwal K., et al. Polymorphic genotypes of the HRES-1 human endogenous retrovirus locus correlate with systemic lupus erythematosus and autoreactivity. Immunogenetics 1999 ; 49: 829-834.
32. Gergely P., Pullmann R., Stancato C., et al. Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus. Clini Immunol 2005 ; 116: 124-134.
33. Ronnblom L., Alm GV An etiopathogenic role for the type I IFN system in SLE. Trends Immunol 2001 ; 22: 427-431.
34. Theofilopoulos AN, Baccala R., Beutler B., Kono DH Type I interferons in immunity and autoimmunity. Ann Rev Immunol 2005 ; 23: 307-336.
35. Pisetsky DS, Vrabie IA Antibodies to DNA: infection or genetics? Lupus 2009 ; 18: 1176-1180.
36. Juarez M., Misischia R., Alarcon GS Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis. Rheum Dis Clin N Am 2003 ; 29: 163-184.
37. Garred P., Voss A., Madsen HO, et al. Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun 2001 ; 2: 442-450.
38. Sturfelt G., Truedsson L. Complement and its breakdown products in SLE. Rheumatology 2005 ; 44: 1227-1232.
39. Huang YF, Wang W., Han JY, et al. Increased frequency of the mannose-binding lectin LX haplotype in Chinese systemic lupus erythematosus patients. Eur J Immunogenet 2003 ; 30: 121-124.
40. Navarra SV, Villamin CA, Baes RP, Pimenta L., Nicdao JL, Bernas GD Increased frequency of mannose-binding lectin promoter LX haplotype among Filipinos with systemic lupus erythematosus. Lupus 2007 ; 16: 147-148.
41. Cuchacovich R., Gedalia A. Pathophysiology and clinical spectrum of infections in systemic lupus erythematosus. Rheum Dis Clin N Am 2009 ; 35: 75-93.
42. Petri M., Genovese M. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins lupus cohort. J Rheumatol 1992 ; 19: 1559-1565.
43. Navarra SV, Dy ER, Arroyo CG, Torralba TP Tuberculosis among Filipino patients with systemic lupus erythematosus. Semin Arthritis Rheum 1996 ; 26: 628-634.
44. Vargas PJ, King G., Navarra SV Central nervous system infections in Filipino patients with systemic lupus erythematosus. Int J Rheum Dis 2009 ; 12: 234-238.
45. Navarra SV, Hamijoyo L. Effect of tuberculosis treatment on steroid requirement in a cohort of Filipino patients with systemic lupus erythematosus [Abstract]. Lupus 2007 ; 16: S227.
46. Ng WL Infections in patients with systemic lupus erythematosus. APLAR J Rheumatol 2006 ; 9: 89-97.
47. Paton NI, Cheong IK, Kong NC, Segasothy M. Risk factors for infection in Malaysian patients with systemic lupus erythematosus. Q J Med 1996 ; 89: 531-538.
48. Lau YL, Lau CS, Chan SY, Karlberg J., Turner MW Mannose-binding protein in Chinese patients with systemic lupus erythematosus. Arthritis Rheum 1996 ; 39: 706-708.
49. Hess EV Lupus: the clinical entity. In: Kammer G, Tsokos G (eds), Lupus molecular and cellular pathogenesis. Totowa, NJ: Humana Press ; 1998. p. 1-11.
50. Bosch X., Guilabert A., Pallares L., et al. Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus 2006 ; 15: 584-589.
51. Gerona J., Navarra SV Salmonella infections in patients with systemic lupus erythematosus: a case series. Int J Rheum Dis 2009 ; 12: 319-323.
52. Ruiz-Irastorza G., Olivares N., Ruiz-Arruza, Martinez-Berriotxoa A., Egurbide MV, Aguirre C. Predictors of major infections in systemic lupus erythematosus. Arthritis Res Ther 2009 ; 11: R109.
53. Reyes CM, Navarra SV Infections among Filipino patients with systemic lupus erythematosus. Phil J Int Med 2005 ; 43: 123-127.
54. Chan TH, Tam LS, Li EK Salmonella infection in Chinese systemic lupus erythematosus patients. Arthritis Rheum 1998 ; 41: S331.
55. Lim E., Koh WH, Loh SF, Lam MS, Howe HS Non-typhoidal salmonellosis in patients with systemic lupus erythematosus. A study of fifty patients and a review of the literature. Lupus 2001 ; 10: 87-92.
56. Tsao CH, Chen CY, Ou LS, Huang JL Risk factors of mortality for Salmonella infection in systemic lupus erythematosus. J Rheumatol 2002 ; 29: 1214-1218.
57. Chen MJ, Tseng HM, Huang YL, et al. Long-term outcome and short-term survival of patients with systemic lupus erythematosus after bacteremia episodes: 6-yr follow-up. Rheumatology 2008 ; 47: 1352-1357.
58. Chu CM, Ng WL, Leung WS, Chan V. Lymphopenia predicts tuberculosis in systemic lupus erythematosus (Abstract). Am J Resp Crit Care Med 2001 ; 163.
59. Phan JC, Bush TM, Donald F., Ward M. Clinical and laboratory features of patients of Vietnamese descent with systemic lupus erythematosus. Lupus 1999 ; 8: 521-524.
60. Erdozain JG, Ruiz-Irastorza G., Egurbide MV, Martinez-Berriotxoa A., Aguirre C. High risk of tuberculosis in systemic lupus erythematosus? Lupus 2006 ; 15: 232-235.
61. Shyam C., Malaviya AN Infection-related morbidity in systemic lupus erythematosus: a clinico-epidemiological study from northern India. Rheumatol Int 1996 ; 16: 1-3.
62. Hung JJ, Ou LS, Lee WI, Huang JL Central nervous system infections in patients with systemic lupus erythematosus. J Rheumatol 2005 ; 32: 40-43.
63. Pope JE, Krizova A., Ouimet JM, Goodwin JL, Laskin MD Close association of herpes zoster reactivation and systemic lupus erythematosus diagnosis: case-control study of patients with SLE or noninflammatory musculoskeletal disorders. J Rheumatol 2004 ; 31: 274-279.
64. Kahl LE Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome. J Rheumatol 1994 Jan; 21: 84-86.
65. Manzi S., Kuller LH, Kutzer J., et al. Herpes zoster in systemic lupus erythematosus. J Rheumatol 1995 Jul; 22: 1254-1258.
66. Park HB, Kim KC, Park JH, et al. Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus. J Rheumatol 2004 ; 31: 2151-2155.
67. Chen HS, Tsai WP, Leu HS, Ho HH, Liou LB Invasive fungal infection in systemic lupus erythematosus: an analysis of 15 cases and a literature review. Rheumatology 2007 ; 46: 539-544.
68. Gluck T., Muller-Ladner U. Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin Infect Dis 2008 ; 46: 1459-1465.
69. Holvast B., Huckriede A., Kallenberg CG, et al. Influenza vaccination in systemic lupus erythematosus: safe and protective? Autoimmune Rev 2007 ; 6: 300-305.
70. Stojanovich L. Influenza vaccination of patients with systemic lupus erythematosus and rheumatoid arthritis. Clin Dev Immunol 2006 ; 13: 373-375.
71. O'Neill SG, Isenberg DA Immunizing patients with systemic lupus erythematosus: a review of effectiveness and safety. Lupus 2006 ; 15: 778-783.
72. Abu-Shakra M. Safety of vaccination of patients with systemic lupus erythematosus. Lupus 2009 ; 18: 1205-1208.
73. Abu-Shakra M., Press J., Buskila D., Sukenik S. Influenza vaccination of patients with systemic lupus erythematosus. Autoimmune Rev 2007 ; 6: 543-546.
74. Mok MY, Lo Y., Chan TM, Wong WS, Lau CS Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy. J Rheumatol 2005 ; 32: 609-615.
75. Gaitonde S., Pathan E., Sule A., Mittal G., Joshi VR Efficacy of isoniazid prophylaxis in patients with systemic lupus erythematosus receiving long term steroid treatment. Ann Rheum Dis 2002 ; 61: 251-253.
76. Iriya SM, Capelozzi VL, Calich I., et al. Causes of death in patients with systemic lupus erythematosus in Sao Paulo, Brazil: a study of 113 autopsies. Arch Intern Med 2001 ; 161: 1557-1561.